<DOC>
	<DOC>NCT01338467</DOC>
	<brief_summary>The aim of the study is to evaluate the effectiveness and the safety of the EYEOP treatment using High Intensity Focused Ultrasound in refractory glaucoma patients.</brief_summary>
	<brief_title>Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Primary open angle glaucoma included pseudoexfoliative glaucoma and pigmentary glaucoma in the study eye with maximally tolerated medical treatment Ocular hypertension defined as an intraocular pressure (IOP) &gt; 21 mm Hg Subject has failed a conventional intraocular glaucoma filtering surgery Patient must be aged 18 years or more No previous intraocular glaucoma surgery or laser treatment in the study eye during the 3 months before HIFU treatment No previous cyclophotocoagulation procedure in the study eye Patient able and willing to provide informed consent and to complete postoperative followup requirements. History of previous glaucoma surgery with implantation of glaucoma drainage device in the study eye History of ocular or retrobulbar tumor Retinal detachment, choroidal hemorrhage or detachment Ocular infectious disease within 14 days before HIFU treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Refractory glaucoma</keyword>
	<keyword>Cyclocoagulation</keyword>
	<keyword>High Intensity Focused Ultrasound</keyword>
</DOC>